Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes Other Scholarly Work

cited authors

  • Kotecha, Rupesh; Mehta, Minesh P

sustainable development goals

authors

publication date

  • August 1, 2020

published in

keywords

  • BEVACIZUMAB
  • Clinical Neurology
  • LYMPHOPENIA
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • PHASE-II
  • RADIATION-THERAPY
  • Science & Technology
  • TRIAL

WoS ID

  • 000593120100005

Digital Object Identifier (DOI)

start page

  • 1062

end page

  • 1064

volume

  • 22

issue

  • 8

open access

  • true